调度器启动，按 Ctrl+C 退出...
2025-06-24 18:38:45.086412
---------IBIO 56.51%
https://cn.tradingview.com/chart/VVrpBNv8/?symbol=NASDAQ%3AIBIO
14 hours ago
iBio Presents Next-Generation Obesity and Cardiometabolic Pipeline Candidates on June 24 Conference Call
iBio在6月24日的电话会议上推出下一代肥胖和心脏代谢管线候选人
---------GIBO 31.06%
https://cn.tradingview.com/chart/VVrpBNv8/?symbol=NASDAQ%3AGIBO
no recent news
---------NKTR 30.4%
https://cn.tradingview.com/chart/VVrpBNv8/?symbol=NASDAQ%3ANKTR
14 hours ago
Nektar to Announce Top-line Data from the 16-Week Induction Period in REZOLVE-AD Phase 2b Study of Rezpegaldesleukin, a Regulatory T-cell Proliferator, in Atopic Dermatitis on June 24, 2025
Nektar将于2025年6月24日公布调节性T细胞增殖剂Rezpegaldesleukin用于特应性皮炎的REZOLVE-AD 2b期研究的16周诱导期顶线数据
---------PSTV 30.06%
https://cn.tradingview.com/chart/VVrpBNv8/?symbol=NASDAQ%3APSTV
no recent news
---------ADIL 20.99%
https://cn.tradingview.com/chart/VVrpBNv8/?symbol=NASDAQ%3AADIL
no recent news
---------SRFM 17.8%
https://cn.tradingview.com/chart/VVrpBNv8/?symbol=NASDAQ%3ASRFM
no recent news
---------OCGN 16.2%
https://cn.tradingview.com/chart/VVrpBNv8/?symbol=NASDAQ%3AOCGN
23 hours ago
Carisma Therapeutics and OrthoCellix Enter into Definitive Merger Agreement to Create Company Focused on Regenerative Cell Therapies for Orthopedic Diseases
Carisma Therapeutics与OrthoCellix签订最终合并协议，成立专注于骨科疾病再生细胞疗法的公司
2025-06-24 18:39:43.520241
---------IMUX 20.04%
https://cn.tradingview.com/chart/VVrpBNv8/?symbol=NASDAQ%3AIMUX
10 minutes ago
Immunic Reports New, Positive Long-Term Open-Label Extension Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis
免疫报告来自复发性多发性硬化症中Vidofludimus钙的2期EMPhASIS试验的新的阳性长期开放标签扩展数据
---------NA 18.55%
https://cn.tradingview.com/chart/VVrpBNv8/?symbol=NASDAQ%3ANA
40 minutes ago
Nano Labs Announces US$500 Million Convertible Notes Private Placement for BNB Treasury Strategy
Nano Labs宣布为BNB国债策略私募5亿美元可转换债券
2025-06-24 18:40:43.802137
2025-06-24 18:41:43.572781
2025-06-24 18:42:43.709826
2025-06-24 18:43:43.601075
---------GWAV 17.86%
https://cn.tradingview.com/chart/VVrpBNv8/?symbol=NASDAQ%3AGWAV
no recent news
2025-06-24 18:44:43.499954
2025-06-24 18:45:43.379722
2025-06-24 18:46:43.733545
2025-06-24 18:47:43.709384
2025-06-24 18:48:43.482498
2025-06-24 18:49:43.828938
2025-06-24 18:50:43.534458
2025-06-24 18:51:43.506003
2025-06-24 18:52:43.362064
2025-06-24 18:53:43.789851
2025-06-24 18:54:43.967249
2025-06-24 18:55:43.463240
2025-06-24 18:56:43.591336
2025-06-24 18:57:43.489383
2025-06-24 18:58:43.847308
2025-06-24 18:59:43.756502
2025-06-24 19:00:43.545221
2025-06-24 19:01:43.825155
2025-06-24 19:02:44.145585
2025-06-24 19:03:44.489274
---------INM 70.61%
https://cn.tradingview.com/chart/VVrpBNv8/?symbol=NASDAQ%3AINM
3 minutes ago
InMed's INM-901 Significantly Reduces Neuroinflammation in Alzheimer's Disease Ex Vivo Study
InMed的INM-901在体外阿尔茨海默病研究中显著减少神经炎症
2025-06-24 19:04:44.011651
2025-06-24 19:05:43.970821
---------AEI 15.38%
https://cn.tradingview.com/chart/VVrpBNv8/?symbol=NASDAQ%3AAEI
14 hours ago
Alset Inc. Announces Stock Repurchase Program
Alset Inc.宣布股票回购计划
2025-06-24 19:06:44.642122
2025-06-24 19:07:44.515044
2025-06-24 19:08:44.479502
2025-06-24 19:09:43.777626
---------XBIO 15.33%
https://cn.tradingview.com/chart/VVrpBNv8/?symbol=NASDAQ%3AXBIO
no recent news
2025-06-24 19:10:43.437598
2025-06-24 19:11:43.566123
2025-06-24 19:12:43.486555
2025-06-24 19:13:43.953339
2025-06-24 19:14:43.637428
2025-06-24 19:15:43.575877
2025-06-24 19:16:43.636968
2025-06-24 19:17:43.797081
2025-06-24 19:18:43.717707
2025-06-24 19:19:43.962456
2025-06-24 19:20:43.475371
2025-06-24 19:21:43.413477
2025-06-24 19:22:43.890144
2025-06-24 19:23:44.180889
2025-06-24 19:24:43.436089
2025-06-24 19:25:43.637098
2025-06-24 19:26:43.541912
2025-06-24 19:27:43.651558
2025-06-24 19:28:44.029931
2025-06-24 19:29:43.757131
2025-06-24 19:30:43.398135
2025-06-24 19:31:43.592763
2025-06-24 19:32:43.661896
2025-06-24 19:33:43.614330
2025-06-24 19:34:43.753593
2025-06-24 19:35:43.664821
2025-06-24 19:36:43.706538
2025-06-24 19:37:43.455723
2025-06-24 19:38:43.385761
2025-06-24 19:39:43.544802
2025-06-24 19:40:43.702925
2025-06-24 19:41:43.721959
2025-06-24 19:42:43.849959
---------OSTX 20.59%
https://cn.tradingview.com/chart/VVrpBNv8/?symbol=NASDAQ%3AOSTX
2 minutes ago
OS Therapies Receives Positive FDA Meeting Feedback on Regulatory Pathway for Accelerated Approval of OST-HER2 in the Prevention or Delay of Recurrent, Fully Resected, Pediatric Lung Metastatic Osteosarcoma
OS疗法在预防或延迟复发、完全切除的儿科肺转移性骨肉瘤中加速批准OST-HER2的监管途径上获得FDA会议正面反馈
2025-06-24 19:43:43.656509
2025-06-24 19:44:43.345423
2025-06-24 19:45:43.957833
2025-06-24 19:46:43.841389
2025-06-24 19:47:43.620132
2025-06-24 19:48:43.522534
2025-06-24 19:49:43.444326
2025-06-24 19:50:43.533024
调度器已关闭
